FERRIC CARBOXYMALTOSE INJECTION

Other

Brand names: Injectafer

Intravenous

Mechanism of Action

12.1 Mechanism of Action Ferric carboxymaltose is a colloidal iron (III) hydroxide in complex with carboxymaltose, a carbohydrate polymer that releases iron.

Indications

See full prescribing information

FDA Warnings

5 WARNINGS AND PRECAUTIONS Hypersensitivity Reactions: Observe for signs and symptoms of hypersensitivity during and after Injectafer administration for at least 30 minutes and until clinically stable following completion of each administration
1 ) Symptomatic Hypophosphatemia: Monitor serum phosphate levels in patients at risk for low serum phosphate who require a repeat course of treatment
1 Hypersensitivity Reactions Serious hypersensitivity reactions, including anaphylactic-type reactions, some of which have been life-threatening and fatal, have been reported in patients receiving Injectafer
Only administer Injectafer when personnel and therapies are immediately available for the treatment of serious hypersensitivity reactions [see Adverse Reactions ( 6

Known Side Effects

11 documented side effects by frequency

Nausea

>10%

Shortness of Breath

1-10%

Vomiting

1-10%

Diarrhea

1-10%

Dizziness

1-10%

Abdominal Pain

1-10%

Headache

1-10%

Itching

1-10%

Constipation

1-10%

Rash

0.1-1%

Back Pain

0.1-1%

Community Discussions

No community discussions found for FERRIC CARBOXYMALTOSE INJECTION yet.

Compare With

0 available comparisons

No comparisons yet.

Formulations

Dosage Forms

Tablet

Route

Intravenous